Literature DB >> 19332270

Myocardial insulin-like growth factor-1 and insulin-like growth factor binding protein-3 gene expression in failing hearts harvested from patients undergoing cardiac transplantation.

Angela Pucci1, Cristina Zanini, Riccarda Granata, Roberta Ghignone, Alberto Iavarone, Fabio Broglio, Paolo Sorrentino, Laura Bergamasco, Mauro Rinaldi, Ezio Ghigo.   

Abstract

Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding proteins (IGFBPs) might play a pathogenic role in heart failure. We showed significantly increased myocardial IGFBP-3 expression (investigated by real-time polymerase chain reaction) and apoptosis (detected by flow cytometry) in 23 failing hearts from patients undergoing cardiac transplantation for end-stage dilated or ischemic cardiomyopathy, when compared with 10 controls. Higher IGF-1 mRNA levels were shown only in end-stage dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332270     DOI: 10.1016/j.healun.2008.12.022

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.

Authors:  Jennifer I Drake; Herman J Bogaard; Shiro Mizuno; Berrick Clifton; Bin Xie; Yuan Gao; Catherine I Dumur; Paul Fawcett; Norbert F Voelkel; Ramesh Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-30       Impact factor: 6.914

2.  Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes.

Authors:  Qingshi Zhao; Amanda J Beck; Joseph M Vitale; Joel S Schneider; Shumin Gao; Corey Chang; Genie Elson; Samuel J Leibovich; Ji Yeon Park; Bin Tian; Hyung-song Nam; Diego Fraidenraich
Journal:  Dev Biol       Date:  2010-10-23       Impact factor: 3.582

3.  Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.

Authors:  Vincenzo Lionetti; Marco Matteucci; Marco Ribezzo; Dario Di Silvestre; Francesca Brambilla; Silvia Agostini; Pierluigi Mauri; Luigi Padeletti; Alessandro Pingitore; Luisa Delsedime; Mauro Rinaldi; Fabio A Recchia; Angela Pucci
Journal:  J Cell Mol Med       Date:  2014-01-20       Impact factor: 5.310

4.  Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.

Authors:  Júlia Aliz Baán; Zoltán V Varga; Przemyslaw Leszek; Mariusz Kuśmierczyk; Tamás Baranyai; László Dux; Péter Ferdinandy; Thomas Braun; Luca Mendler
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

5.  Biventricular differences in β-adrenergic receptor signaling following burn injury.

Authors:  Ashley N Guillory; Robert P Clayton; Anesh Prasai; Amina El Ayadi; David N Herndon; Celeste C Finnerty
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

6.  Identification of the molecular mechanisms underlying dilated cardiomyopathy via bioinformatic analysis of gene expression profiles.

Authors:  Hu Zhang; Zhuo Yu; Jianchao He; Baotong Hua; Guiming Zhang
Journal:  Exp Ther Med       Date:  2016-12-05       Impact factor: 2.447

Review 7.  Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies.

Authors:  Andreas Hoeflich; Robert David; Rikke Hjortebjerg
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-16       Impact factor: 5.555

8.  Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats.

Authors:  Francesca Forini; Vincenzo Lionetti; Hossein Ardehali; Angela Pucci; Federica Cecchetti; Mohsen Ghanefar; Giuseppina Nicolini; Yoshihiko Ichikawa; Monica Nannipieri; Fabio A Recchia; Giorgio Iervasi
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

9.  Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics.

Authors:  Salaheldin Ahmed; Abdulla Ahmed; Habib Bouzina; Jakob Lundgren; Göran Rådegran
Journal:  Heart Vessels       Date:  2020-07-10       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.